Insulin and IGF-I receptors (IR and IGF-IR) 3 are heterotetrameric oligomers sharing a high degree of homology. They consist of two extracellular 135-kDa ␣ subunits that contain the ligand domain and two 95-kDa transmembrane  subunits endowed of tyrosine kinase activity (1, 2). Insulin and IGF-I binding to the receptor ␣ subunits stimulates autophosphorylation of the receptor cytoplasmic  tail at multiple tyrosine residues. Activated  subunits interact with and phosphorylate several intracellular substrates at tyrosine residues, including the IRS family proteins (IRS-1/2/3/4) and Gab1 (1, 2). These tyrosine-phosphorylated substrates provide docking sites for SH2-contanining proteins, including p85, the regulatory subunits of phosphatidylinositol 3-kinase, and Grb2, a small adapter protein involved in the activation of the Ras pathway (1-3). Activation of the phosphatidylinositol 3-kinase pathway stimulates Akt and, as a consequence, elicits metabolic effects. On the other hand, the recruitment of Grb2 results in the activation of the Ras/ERK pathway, which in turn regulates cell proliferation and differentiation (1-3).Despite the high similarity between IR and IGF-IR, these two receptors display different effects: IR mainly elicits metabolic effects, including glucose uptake and glycogen synthesis, and IGF-IR mainly stimulates cell proliferation, survival, and differentiation. The mechanisms underlying the different actions of IR and IGF-IR have been extensively studied and are believed to depend on the preferential recruitment and activation of different intracellular substrates, including CrkII, Grb10, 14-3-3, and the focal adhesion kinase (FAK) (1-3).The FAK is an ubiquitously expressed cytoplasmic tyrosine kinase, involved in integrin and growth factor receptor signaling. It is widely accepted that FAK is a point of convergence in the actions of the extracellular matrix and growth factors (4). FAK tyrosine phosphorylation occurs rapidly in response to growth factor stimulation including PDGF, epidermal growth factor, and IGF-I (4, 5). In particular, FAK phosphorylation at tyrosine 925 creates a binding site for the SH2 domain of Grb2, thereby activating the Ras/ERK pathway (6). Moreover, the activated FAK phosphorylates several adapter proteins including the p130 CAS (7) and paxillin (8), which in turn provide docking sites to the small SH2-containing proteins Crk and Nck (7, 9, 10). Similarly to Grb2, also Crk and Nck recruitment results in the activation of the Ras/ERK pathway (4). Because FAK is able to trigger the Ras pathway in response to several stimuli, it has been proposed that FAK plays a major role in mediating the effect of tyrosine kinase receptors on the ERK activation. Evidence supporting this hypothesis was obtained in FAK Ϫ/Ϫ cells, which exhibit a defect in ERK activation in response to serum and PDGF stimulation (11). Moreover, in NIH3T3 fibroblasts the overexpression of a dominant negative FAK blocks seruminduced activation of ERK (12). At variance with most growth factors, which sti...